Immunodiagnostic Systems Hldgs PLC Receives “Hold” Rating from N+1 Singer (IDH)
Immunodiagnostic Systems Hldgs PLC (LON:IDH)‘s stock had its “hold” rating reaffirmed by analysts at N+1 Singer in a research report issued to clients and investors on Wednesday, AnalystRatingsNetwork reports. They currently have a GBX 504 ($8.47) price target on the stock. N+1 Singer’s price target suggests a potential downside of 2.70% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the stock. Analysts at Nplus1 Brewin reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Tuesday, April 15th. They now have a GBX 453 ($7.61) price target on the stock. Analysts at FinnCap reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Tuesday, April 15th. They now have a GBX 450 ($7.56) price target on the stock. Six equities research analysts have rated the stock with a hold rating, Immunodiagnostic Systems Hldgs PLC presently has a consensus rating of “Hold” and a consensus price target of GBX 486.83 ($8.18).
Immunodiagnostic Systems Hldgs PLC (LON:IDH) traded up 1.07% during mid-day trading on Wednesday, hitting GBX 518.00. The stock had a trading volume of 39,912 shares. Immunodiagnostic Systems Hldgs PLC has a one year low of GBX 356.00 and a one year high of GBX 593.00. The stock’s 50-day moving average is GBX 501.1 and its 200-day moving average is GBX 524.3.
Immunodiagnostic Systems Holdings plc (LON:IDH) is engaged in manufacturing and distributing medical diagnostic products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.